COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resource...
Enfermedades Gastrointestinales/terapia, Enfermedades Gastrointestinales/diagnóstico, Hepatopatías/terapia, Hepatopatías/diagnóstico, Inmunidad Activa/inmunología, Inmunidad Activa/efectos de los fármacos, Betacoronavirus, Infecciones por Coronavirus/prevención & control, Neumonía Viral/prevención & control